semaglutide vs sglt2 GLP-1 Receptor Agonist Therapy With and Without Inhibitors in Patients With Type 2 Diabetes SGLT2 Inhibitors vs. GLP-1 Agonists

The lack of comprehensive endotoxin testing and selective batch verification raises questions about paying double budget vendor costs for marginally better quality assurance

Greto, PhD student, for her invaluable help in searching PubMed for data for this Review

Days with important meetings, heavy workouts, social obligations, or high-stakes tasks score higher

Formula developers need to check at least five interfaces: active and surfactant compatibility, acid or alkali versus metal and liner, fragrance drift under solvent and propellant, propellant impact on droplet size and cleaning rate, and valve/nozzle tolerance against surfactant deposit or crystallization